This AI can diagnose cognitive disorders from how people type
Cambridge, Massachusetts-based nQ Medical is patenting an artificial intelligence that can assess a person’s health based on how they type.
Orthocell’s patch for torn ligaments could do away with sutures
A patent application from Orthocell, an Australian regenerative medicine company, describes a patch for damaged soft tissue meant to replace sutures.
Biosensors can tell if a single cancer cell is capable of spreading
A patent application from the University of California (UC) discloses a method for measuring the metastatic potential in single living cancer cells.
This smart TV displays health information based on viewers’ facial features
FaceHeart, a Taiwanese AI company, is patenting a health monitoring function for smart televisions, one that bases its data on a viewer’s facial features.
Novel PTSD treatment promises fewer side effects
One of Brazil’s largest pharmaceutical companies, covers a drug said to be more effective at treating post-traumatic stress disorder (PTSD) than current medical options, with fewer side effects to boot.
Platform enables newborn resuscitation without cord cutting
A patent application from the Netherlands’ Leiden University Medical Center (LUMC) describes a medical apparatus that enables the resuscitation of a newborn without distancing it from its mother, while also facilitating delayed cord clamping.
Blood samples can be tested for Down Syndrome-associated biomarkers
Biomarkers for Down syndrome-associated conditions can be identified from blood samples, according to a recently published patent application that also details how such biomarkers can be used to develop specific treatments for affected individuals.
First vaccine to fully immunize against malaria builds on pandemic-driven RNA tech
Researchers have invented a promising new blueprint for one — with properties akin to the novel RNA-based vaccine for COVID-19.
USPTO publishes patent application for Sanofi’s abandoned, yet promising Zika vaccine
The U.S. Patent and Trademark Office publishes the patent application for what could have been the first vaccine for Zika virus, nearly four years after Sanofi abandoned its development.
Ajinomoto patenting ketogenic drinks to treat epilepsy
Japanese food and biotechnology company Ajinomoto is patenting a supplementary treatment for people suffering from drug-resistant epilepsy: a drinkable formula based on popular ketogenic diets.
